On a regular day, Neuralink, led by Elon Musk, made an announcement that could change what we believe is possible for humanity. The FDA granted its breakthrough device designation to Blindsight, a neural implant that aims to restore vision for those who have lost it. While this news is extraordinary, it also raises a flood of questions about the practicality, ethics, and future of such technology.

Blindsight isn’t just another tech gadget; it’s a symbol of hope for millions. The implant works by placing a microelectrode array into the brain’s visual cortex, activating neurons to deliver visual images to the user. Musk claims this technology could even help those who’ve lost both eyes and their optic nerves regain sight, as long as their visual cortex remains functional. Imagine people who have never seen before gaining the ability to do so, or those who lost their sight being able to see again.

Always quick to balance vision with reality, Musk likened the initial visual resolution to old Atari graphics. Yet, he teased the possibility of future upgrades, with vision surpassing what nature offers, potentially letting people see in infrared, ultraviolet, or even radar. It’s a concept that feels like it was pulled straight from science fiction, yet it’s grounded in current scientific developments.

But Neuralink’s ambitions don’t stop at restoring sight. The company is also venturing into brain-computer interfaces, or BCIs, aimed at helping people with quadriplegia control digital devices through sheer thought. Earlier this year, Neuralink implanted its first device in a patient, who has since used it for tasks such as playing video games and online chess. The long-term goal? A platform that can connect with every aspect of the human brain, functioning as a universal input and output system.

The FDA’s designation as a breakthrough device doesn’t just sound good—it has real benefits. It allows Neuralink to work more closely with FDA experts, accelerating the development process. If all goes well, Blindsight might make it to market faster than expected, offering hope to millions who have lost their vision.

However, despite the optimism, the road to bringing Blindsight to life is filled with challenges. Neuralink isn’t the only company trying to develop vision-restoring implants, and the science behind fully restoring vision is incredibly complex. Some experts doubt whether it’s possible to restore vision to those who have been blind from birth, as their brains might not have developed the pathways needed to process visual information. This raises important questions about how much Blindsight can truly achieve.

Ethical questions also linger. Neuralink’s practices involving animal testing have come under the microscope, with reports that federal investigators are looking into their methods. Musk has assured the public that no animals have been seriously harmed, but that doesn’t eliminate the ethical concerns surrounding the testing process.

There’s no simple answer to the ethical dilemmas Blindsight presents. On one hand, the potential to restore sight is undoubtedly transformative. But on the other, the means to that end need thorough scrutiny. Animal testing, though common in medical research, always stirs up debate about the moral costs involved. Is the promise of such a technology worth what it might take to achieve?

Beyond sight restoration, the implications of brain-computer interfaces touch on something much deeper. As technology becomes more integrated with our bodies, what happens to the social and psychological fabric of society? Will this new frontier create an even bigger gap between those who can afford such advancements and those who can’t? How do we adapt to a world where our natural abilities can be augmented by machines?

Yet for all these challenges, Blindsight is undeniably a leap forward in medical technology. The FDA’s breakthrough designation offers a path for quicker development and approval, bringing us closer to a future where this technology could change lives. But a lot of hard work still lies ahead before Blindsight can become a practical solution for vision loss.

The next few years will be crucial for Neuralink’s vision to either become reality or fade into the background. The road ahead will be full of both victories and setbacks, requiring careful thought on the ethical questions it raises. Like any groundbreaking technology, the journey is as much about solving problems as it is about pushing boundaries.

Blindsight may hold the key to giving vision back to the blind, but the journey to making it a reality is filled with obstacles—ethical, technical, and societal. We must navigate these carefully as we weigh the benefits against the potential costs. The future of Blindsight, and brain-computer interfaces as a whole, will depend on how well we can handle these challenges with responsibility and care. If Neuralink succeeds, Blindsight could offer people who’ve lost their sight a way to see the world once more, changing lives and redefining what humans are capable of.

Read: Does the brain really consume less energy than a computer?